MetaCap

Chemed Corp (CHE)

NYSE: CHEHealth CareMedical/Nursing ServicesUSD

501.45-8.39 (-1.65%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

CHE stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
$19.55
Dividend yield
0.48% ($2.40)
Ex-dividend date
Aug 17, 2026
52-week range
365.21 – 557.00
Day range
499.52 – 510.48
Volume / Avg
139.13K / 160.12K
Beta
—
Next earnings
Oct 27, 2026

52-week range

$365.21$557.00

CHE stock today

Chemed (CHE) closed at $501.45 on Oct 7, down 1.65% (-$8.39), versus the S&P 500's 0.22% decline. At this level, CHE sits in the middle of its 52-week range of $365.21 to $557.00: 10.0% below the high, set on Aug 10, 2026 and 37.3% above the low. CHE is up 17.2% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 15.0%.

At 25.6x trailing earnings, Chemed trades below the peer-group median of 33.5x. Its forward P/E of 18.2x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. The company is scheduled to report Sep/2026 results on Oct 27 after the market closes; analysts expect EPS of $5.93. Chemed pays an annual dividend of $2.40 per share, a 0.48% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About Chemed

Company profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Industry
Medical/Nursing Services
CEO
Mr. Kevin J. McNamara
Headquarters
Cincinnati, OH
Employees
15,811
Website
chemed.com

Financial highlights

Full financials

In fiscal 2025, Chemed generated $2.53 billion in revenue, up 4.1% from fiscal 2024, its 3rd consecutive year of revenue growth. Net income was $265.2 million (-12.2% year over year), for a net margin of 10.5% versus a median of 12.4% in the prior 5 years. Gross margin was 32.5% (down from 35.1%) and operating margin 13.4%.

Chemed annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$2.53B$2.43B$2.26B$2.13B$2.14B
Growth+4.06%+7.37%+6.06%-0.20%+2.87%
Net income$265.24M$302.00M$272.51M$249.62M$268.55M
EPS (diluted)$18.34$19.89$17.93$16.53$16.85

Analyst forecast

Forecast

Consensus (5 analysts)

buy

Avg. price target

$571.60+13.99%

  • Strong buy 0
  • Buy 2
  • Hold 3
  • Sell 0
  • Strong sell 0

Target range

Low $520.00High $650.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Next report
Oct 27, 2026
EPS estimate
$5.93
Last reported (Q2 2026)
Jul 31, 2026
EPS actual vs est.
$5.13 vs —

Dividends

Dividend history
Annual dividend
$2.40
Last payment
$0.70
Ex-dividend date
Aug 17, 2026

CHE news

All CHE news

Chemed peers

Health Care sector
CHE peer companies
CompanyPrice% ChgMarket capCompare
HIMSHims & Hers Health Inc. Class A29.54+0.24%$6.89Bvs CHE
OPCHOption Care Health Inc.31.01+0.03%$4.65Bvs CHE
LFSTLifeStance Health Group Inc.12.11-0.08%$4.60Bvs CHE
AVAHAveanna Healthcare Holdings Inc.12.31+0.74%$2.69Bvs CHE
PRVAPrivia Health Group Inc.20.30+0.10%$2.59Bvs CHE
ADUSAddus HomeCare Corporation113.27+0.10%$2.12Bvs CHE
WGSGeneDx Holdings Corp. Class A68.53-4.18%$2.04Bvs CHE
PNTGThe Pennant Group Inc.39.62-0.84%$1.38Bvs CHE

Indexes, lists and sector

Chemed stock FAQ

What is Chemed's stock price today?

CHE last traded at $501.45 as of Oct 7, 4:00 PM EDT, down 1.65% on the day. Prices are delayed at least 15 minutes.

Does Chemed pay a dividend?

Yes. Chemed pays $2.40 per share annually, a 0.48% yield. The most recent dividend of $0.70 had an ex-dividend date of Aug 17, 2026.

When is Chemed's next earnings date?

Chemed is expected to report earnings on Tuesday, October 27, 2026. Analysts expect EPS of $5.93.

What is CHE's P/E ratio?

CHE trades at a trailing P/E ratio of 25.65 and a forward P/E of 18.22, compared with a median of 33.5 for its closest peers.

Who is Chemed's CEO?

Mr. Kevin J. McNamara is the chief executive officer of Chemed Corp, which has about 15,811 employees.

Has CHE ever split its stock?

Yes. The most recent CHE stock split was a 2-for-1 split on May 12, 2005, one of 2 splits on record.

What is the CHE 52-week high?

The 52-week high for CHE is $557.00 and the 52-week low is $365.21. The stock is currently 10.0% below its high.

Compare CHE